Børresen-Dale AL - Search Results

1

The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer.

Silwal-Pandit L, Russnes H, Borgen E, Skarpeteig V, Moen Vollan HK, Schlichting E, Kåresen R, Naume B, Børresen-Dale AL, Farnebo M, Langerød A. Silwal-Pandit L, et al. PLoS One. 2015 Oct 13;10(10):e0139965. doi: 10.1371/journal.pone.0139965. eCollection 2015. PLoS One. 2015. PMID: 26460974 Free PMC article.

2

Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM.

Laake K, Odegård A, Andersen TI, Bukholm IK, Kåresen R, Nesland JM, Ottestad L, Shiloh Y, Børresen-Dale AL. Laake K, et al. Genes Chromosomes Cancer. 1997 Mar;18(3):175-80. Genes Chromosomes Cancer. 1997. PMID: 9071570

3

Interaction between bcl-2 and p21 (WAF1/CIP1) in breast carcinomas with wild-type p53.

Bukholm IK, Nesland JM, Kåresen R, Jacobsen U, Børresen-Dale AL. Bukholm IK, et al. Int J Cancer. 1997 Sep 26;73(1):38-41. doi: 10.1002/(sici)1097-0215(19970926)73:1<38::aid-ijc7>3.0.co;2-2. Int J Cancer. 1997. PMID: 9334807

4

Expression of E-cadherin and its relation to the p53 protein status in human breast carcinomas.

Bukholm IK, Nesland JM, Kåresen R, Jacobsen U, Børresen-Dale AL. Bukholm IK, et al. Virchows Arch. 1997 Nov;431(5):317-21. doi: 10.1007/s004280050105. Virchows Arch. 1997. PMID: 9463572

5

E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma.

Bukholm IK, Nesland JM, Kåresen R, Jacobsen U, Børresen-Dale AL. Bukholm IK, et al. J Pathol. 1998 Jul;185(3):262-6. doi: 10.1002/(SICI)1096-9896(199807)185:3<262::AID-PATH97>3.0.CO;2-Y. J Pathol. 1998. PMID: 9771479

6

CYP17 and breast cancer risk: the polymorphism in the 5' flanking area of the gene does not influence binding to Sp-1.

Nedelcheva Kristensen V, Haraldsen EK, Anderson KB, Lønning PE, Erikstein B, Kåresen R, Gabrielsen OS, Børresen-Dale AL. Nedelcheva Kristensen V, et al. Cancer Res. 1999 Jun 15;59(12):2825-8. Cancer Res. 1999. PMID: 10383140

7

BRCA1 screening in patients with a family history of breast or ovarian cancer.

Arver B, Claro A, Langerød A, Børresen-Dale AL, Lindblom A. Arver B, et al. Genet Test. 1999;3(2):223-6. doi: 10.1089/gte.1999.3.223. Genet Test. 1999. PMID: 10464672

8

Genetic variants of CYP19 (aromatase) and breast cancer risk.

Kristensen VN, Harada N, Yoshimura N, Haraldsen E, Lonning PE, Erikstein B, Kåresen R, Kristensen T, Børresen-Dale AL. Kristensen VN, et al. Oncogene. 2000 Mar 2;19(10):1329-33. doi: 10.1038/sj.onc.1203425. Oncogene. 2000. PMID: 10713674

9

Screening breast cancer patients for Norwegian ATM mutations.

Laake K, Vu P, Andersen TI, Erikstein B, Kåresen R, Lonning PE, Skovlund E, Børresen-Dale AL. Laake K, et al. Br J Cancer. 2000 Dec;83(12):1650-3. doi: 10.1054/bjoc.2000.1519. Br J Cancer. 2000. PMID: 11104561 Free PMC article.

10

High frequency of skewed X inactivation in young breast cancer patients.

Kristiansen M, Langerød A, Knudsen GP, Weber BL, Børresen-Dale AL, Orstavik KH. Kristiansen M, et al. J Med Genet. 2002 Jan;39(1):30-3. doi: 10.1136/jmg.39.1.30. J Med Genet. 2002. PMID: 11826021 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

511 results

Search Page

Filters